BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22879463)

  • 1. BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.
    Quartuccio L; Salvin S; Fabris M; Maset M; Pontarini E; Isola M; De Vita S
    Rheumatology (Oxford); 2013 Feb; 52(2):276-81. PubMed ID: 22879463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
    De Vita S; Quartuccio L; Salvin S; Corazza L; Zabotti A; Fabris M
    Rheumatology (Oxford); 2012 Apr; 51(4):627-33. PubMed ID: 22210656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The B-lymphocyte stimulator connection in Sjogren's syndrome.
    Ramos-Casals M
    Rheumatology (Oxford); 2013 Feb; 52(2):223-5. PubMed ID: 23041596
    [No Abstract]   [Full Text] [Related]  

  • 4. T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjögren's syndrome.
    Pivetta B; De Vita S; Ferraccioli G; De Re V; Gloghini A; Marzotto A; Caruso G; Dolcetti R; Bartoli E; Carbone A; Boiocchi M
    J Rheumatol; 1999 May; 26(5):1101-9. PubMed ID: 10332975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection.
    Fabris M; Quartuccio L; Sacco S; De Marchi G; Pozzato G; Mazzaro C; Ferraccioli G; Migone TS; De Vita S
    Rheumatology (Oxford); 2007 Jan; 46(1):37-43. PubMed ID: 16735452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
    De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
    Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjögren's syndrome.
    Gellrich S; Rutz S; Borkowski A; Golembowski S; Gromnica-Ihle E; Sterry W; Jahn S
    Arthritis Rheum; 1999 Feb; 42(2):240-7. PubMed ID: 10025917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome.
    De Vita S; Boiocchi M; Sorrentino D; Carbone A; Avellini C; Dolcetti R; Marzotto A; Gloghini A; Bartoli E; Beltrami CA; Ferraccioli G
    Arthritis Rheum; 1997 Feb; 40(2):318-31. PubMed ID: 9041944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
    Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
    Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
    Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
    Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
    Pers JO; Devauchelle V; Daridon C; Bendaoud B; Le Berre R; Bordron A; Hutin P; Renaudineau Y; Dueymes M; Loisel S; Berthou C; Saraux A; Youinou P
    Arthritis Rheum; 2007 May; 56(5):1464-77. PubMed ID: 17469105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
    Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of clonally expanded salivary gland lymphocytes in Sjögren's syndrome.
    Freimark B; Fantozzi R; Bone R; Bordin G; Fox R
    Arthritis Rheum; 1989 Jul; 32(7):859-69. PubMed ID: 2546568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
    Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-centromere antibody-positive Sjögren's syndrome: A distinct clinical subgroup?
    Lee KE; Kang JH; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Lee SS
    Int J Rheum Dis; 2015 Sep; 18(7):776-82. PubMed ID: 26179502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
    Hamza N; Bootsma H; Yuvaraj S; Spijkervet FK; Haacke EA; Pollard RP; Visser A; Vissink A; Kallenberg CG; Kroese FG; Bos NA
    Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.
    Christodoulou MI; Kapsogeorgou EK; Moutsopoulos NM; Moutsopoulos HM
    Am J Pathol; 2008 Nov; 173(5):1389-96. PubMed ID: 18818377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.